Wells Fargo & Company »

Mineralys Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $186k 14k 12.91
2023-12-31 $69k 8.0k 8.60
2023-09-30 $47k 4.9k 9.51
2023-06-30 $108k 6.3k 17.05